JW THERAP-B 02126·

Gross margin ------------29.37%--40.33%10.96%50.74%10.42%48.87%1.88%61.02%12.15% Net margin -------------2280.51%---580.73%1699.78%-441.74%138.99%-373.30%68.44%-195.76%177.53% ROE -------------25.17%---35.94%10.77%-45.61%9.67%-50.52%4.91%-99.83%49.31% ROA -------------22.54%---30.31%7.78%-35.79%5.47%-35.15%0.64%-56.27%21.12% Revenue growth ----------------373.10%--19.32%353.78%-8.99%28.32%79.28%88.27% Attributable profit growth -----------------20.48%--9.23%29.71%23.10%13.86%5.98%17.11% Debt-to-assets 172.85%--357.29%184.44%----10.45%--15.66%5.21%21.54%5.88%30.42%8.88%43.64%13.21% Current ratio 0.25--0.170.08----9.53--4.784.754.040.741.742.301.450.29 Operating cash flow / net profit ------------0.80--0.630.160.520.120.560.050.140.43 Operating cash flow / revenue -------------1822.25%---368.37%1453.88%-229.17%139.20%-210.75%18.42%-27.09%183.66%

Gross margin 61.23%--51.82%9.41% Net margin -251.32%---45.28%206.03% Revenue growth ----4.71%-- Attributable profit growth ----81.13%-- Debt-to-assets ----45.70%-- Current ratio ----1.43--

Revenue ------------30.80M--145.70M373.10%173.86M19.32%158.22M8.99%283.65M79.28% Other income and gains ------------6.44M--23.38M262.82%8.25M64.72%6.87M16.68%5.62M18.20% Gross profit ------------9.04M--58.76M549.60%88.22M50.14%77.32M12.36%173.08M123.86% Selling and distribution expenses ------------170.73M--190.88M11.80%113.20M40.70%140.41M24.04%154.34M9.92% Administrative expenses ------------201.52M--179.76M10.80%140.05M22.09%120.07M14.27%78.49M34.63% Net finance costs ------------2.69M--6.79M152.12%12.41M82.92%12.22M1.57%11.43M6.43% Income tax ----------------------------3.07M-- Operating profit -------------759.08M---855.88M12.75%-789.61M7.74%-606.84M23.15%-561.75M7.43% Profit before tax -------------702.33M---846.13M20.48%-768.00M9.23%-590.62M23.10%-552.23M6.50% Net profit -------------702.33M---846.13M20.48%-768.00M9.23%-590.62M23.10%-555.29M5.98% Net profit attributable to owners -------------702.33M---846.13M20.48%-768.00M9.23%-590.62M23.10%-555.29M5.98%

Revenue 106.35M--111.35M4.71% Other income and gains 4.28M--578.00K86.50% Cost of sales 41.23M--53.65M30.12% Gross profit 65.12M--57.71M11.38% Selling and distribution expenses 58.49M--68.84M17.68% Administrative expenses 32.19M--32.05M0.44% Net finance costs 6.18M--231.00K96.26% Income tax 0--0-- Profit before tax -267.26M---50.43M81.13% Net profit -267.26M---50.43M81.13%

Cash and cash equivalents 4.54M--7.80M71.76%----1.83B--1.38B24.59%1.01B27.28%757.38M24.71%503.07M33.58% Trade and bills receivables ----------------5.30M-------------- Inventories ------------31.40M--40.16M27.89%34.78M13.40%31.26M10.12%62.00M98.37% Total current assets 5.50M--9.17M66.71%----1.90B--1.49B21.63%1.07B28.12%808.67M24.24%570.30M29.48% Total assets 12.64M--14.96M18.35%----3.12B--2.79B10.44%2.15B23.12%1.68B21.70%986.89M41.27% Total current liabilities 21.85M--53.46M144.64%----198.90M--310.83M56.28%264.47M14.92%465.05M75.84%394.39M15.19% Total liabilities 21.85M--53.46M144.64%----325.75M--437.06M34.17%462.26M5.76%511.20M10.59%430.63M15.76% Equity attributable to owners -9.21M---38.50M317.98%----2.79B--2.35B15.64%1.68B28.48%1.17B30.57%556.26M52.42% Total equity -9.21M---38.50M317.98%----2.79B--2.35B15.64%1.68B28.48%1.17B30.57%556.26M52.42%

Cash and cash equivalents ----392.09M-- Inventories ----50.94M-- Total current assets ----451.28M-- Total assets ----833.18M-- Total current liabilities ----315.06M-- Total liabilities ----380.78M-- Total equity ----452.40M--

Net cash from operating activities 0---16.35M-------561.20M---536.72M4.36%-398.42M25.77%-333.44M16.31%-76.85M76.95% Net cash from investing activities -2.34M---10.32M340.79%-----137.13M---124.08M9.51%9.90M107.98%-15.43M255.75%-1.49M90.35% Net cash from financing activities 7.92M--30.69M287.56%-----30.62M--112.35M466.92%275.00K99.76%90.49M32805.45%-169.81M287.66% Net change in cash 5.58M--4.02M27.95%-----728.95M---548.45M24.76%-377.43M31.18%-248.53M34.15%-254.31M2.32%